GlucoTrack, Inc. GCTK
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.46M | 6.72M | 6.28M | 6.57M | 6.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.40M | 16.80M | 16.09M | 16.46M | 15.40M |
| Operating Income | -15.40M | -16.80M | -16.09M | -16.46M | -15.40M |
| Income Before Tax | -15.95M | -16.89M | -19.39M | -25.85M | -26.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -15.95 | -16.89 | -19.39 | -25.85 | -26.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.95M | -16.89M | -19.39M | -25.85M | -26.77M |
| EBIT | -15.40M | -16.80M | -16.09M | -16.46M | -15.40M |
| EBITDA | -15.33M | -16.74M | -16.05M | -16.42M | -15.36M |
| EPS Basic | -360.57 | -626.27 | -546.89 | -427.67 | -288.54 |
| Normalized Basic EPS | -224.36 | -391.42 | -341.81 | -267.29 | -180.34 |
| EPS Diluted | -360.57 | -626.27 | -546.89 | -427.67 | -288.54 |
| Normalized Diluted EPS | -224.36 | -391.42 | -341.81 | -267.29 | -180.34 |
| Average Basic Shares Outstanding | 282.00K | 131.50K | 76.90K | 46.50K | 16.50K |
| Average Diluted Shares Outstanding | 282.00K | 131.50K | 76.90K | 46.50K | 16.50K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |